I agree that this site is using cookies. You can find further informations here.
X
Alleva, David
62  results:
Search for persons X
?
1

Use of protective antigen of Bacillus anthracis as a model ..:

Inglefield, Jon ; Catania, Jason ; Harris, Andrea...
Vaccine.  40 (2022)  38 - p. 5544-5555 , 2022
Link: https://doi.org/10.1016/..
 
?
2

T.84. Efficacy of a Novel Synthetic Steroid, TRIOLEX™ (17α-..:

Alleva, David ; Nicoletti, Ferdinando ; Mangano, Katia...
Clinical Immunology.  131 (2009)  - p. S75 , 2009
Link: https://doi.org/10.1016/..
 
?
3

T.89. Clinical Results of a Phase II Trial in Ulcerative Co..:

Reading, Christopher ; Alleva, David ; McNeeley, Patricia...
Clinical Immunology.  131 (2009)  - p. S76-S77 , 2009
Link: https://doi.org/10.1016/..
 
?
4

Sa.56. Efficacy Of XOMA 052 Anti-IL-1β Antibody In The DBA/..:

Owyang, Alex ; Esposito, Lin ; Vanegas, Sandra...
Clinical Immunology.  127 (2008)  - p. S98-S99 , 2008
Link: https://doi.org/10.1016/..
 
?
5

An antigen-specific immunotherapeutic, AKS-107, deletes ins..:

Alleva, David G. ; Delpero, Andrea R. ; Sathiyaseelan, Thillainaygam...
Frontiers in Immunology.  15 (2024)  - p. , 2024
Link: https://doi.org/10.3389/..
 
?
6

Immunogenicity phase II study evaluating booster capacity o..:

Alleva, David G. ; Feitsma, Eline A. ; Janssen, Yester F....
npj Vaccines.  9 (2024)  1 - p. , 2024
Link: https://doi.org/10.1038/..
 
?
7

A randomized phase I/II safety and immunogenicity study of ..:

Feitsma, Eline A. ; Janssen, Yester F. ; Boersma, Hendrikus H....
Vaccine.  41 (2023)  13 - p. 2184-2197 , 2023
Link: https://doi.org/10.1016/..
 
?
8

Phase I interim results of a phase I/II study of the IgG-Fc..:

Janssen, Yester F. ; Feitsma, Eline A. ; Boersma, Hendrikus H....
Vaccine.  40 (2022)  9 - p. 1253-1260 , 2022
Link: https://doi.org/10.1016/..
 
?
9

Development of an IgG-Fc fusion COVID-19 subunit vaccine, A..:

Alleva, David G. ; Delpero, Andrea R. ; Scully, Melanie M....
Vaccine.  39 (2021)  45 - p. 6601-6613 , 2021
Link: https://doi.org/10.1016/..
 
?
10

Reversal of Hyperglycemia and Suppression of Type 1 Diabete..:

Alleva, David G. ; Rezaee, Melika ; Yip, Linda...
Biomedicines.  8 (2020)  3 - p. 53 , 2020
Link: https://doi.org/10.3390/..
 
?
11

Enhanced early innate and T cell-mediated responses in subj..:

Minang, Jacob T. ; Inglefield, Jon R. ; Harris, Andrea M....
Vaccine.  32 (2014)  50 - p. 6847-6854 , 2014
Link: https://doi.org/10.1016/..
 
?
12

A high-throughput chemotaxis assay for pharmacological char..:

Ott, Thomas R. ; Pahuja, Anil ; Lio, Francisco M....
Journal of Pharmacological and Toxicological Methods.  51 (2005)  2 - p. 105-114 , 2005
Link: https://doi.org/10.1016/..
 
?
13

Identification of CC Chemokine Receptor 7 Residues Importan..:

Ott, Thomas R. ; Pahuja, Anil ; Nickolls, Sarah A...
Journal of Biological Chemistry.  279 (2004)  41 - p. 42383-42392 , 2004
Link: https://doi.org/10.1074/..
 
?
14

Regulation of murine macrophage proinflammatory and anti-in..:

Alleva, David G ; Johnson, Eric B ; Lio, Francisco M...
Journal of Leukocyte Biology.  71 (2002)  4 - p. 677-685 , 2002
Link: https://doi.org/10.1189/..
 
?
15

SJL and NOD macrophages are uniquely characterized by genet..:

Alleva, David G ; Johnson, Eric B ; Wilson, Jerry..
Journal of Leukocyte Biology.  69 (2001)  3 - p. 440-448 , 2001
Link: https://doi.org/10.1189/..
 
1-15